LTGO
Latigo Biotherapeutics, Inc.
15.90$
-4.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2024 | 2025 |
|---|---|---|
| 100.0% | 100.0% | |
| 92.6% | 97.8% | |
| 78.4% | 92.0% | |
| 666.8% | 406.8% | |
| 63.1% | 24.4% | |
| 30.9% | 6.6% | |
| -566.8% | -306.8% | |
| -585.9% | -322.0% | |
| 263.1% | 79.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.